André Strydom

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.1Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

EClinicalMedicine(2021)10.1016/j.eclinm.2021.100769

Top 6%

3.5DataRank

Top 6%114 citations

Alberto C. S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole Baumer +17 more

Papers

Driven by 21 papers — median percentile 80. Top paper: “Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey”.

Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

EClinicalMedicine(2021)10.1016/j.eclinm.2021.100769

Top 6%

3.5DataRank

Top 6%114 citations

Alberto C. S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole Baumer +17 more

A multicentre validation study of the diagnostic value of plasma neurofilament light

Nature Communications(2021)10.1038/s41467-021-23620-z

N/A

0.950DataRank · unranked

561 citations

Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma L. van der Ende, Thomas K. Karikari +36 more

Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium

Alzheimer s & Dementia(2024)10.1002/alz.13779

Top 34%

0.576DataRank

Top 34%30 citations

R. Asaad Baksh, Eimear McGlinchey, Ellen Melbye Langballe, Bessy Benejam, Jessica Beresford‐Webb +11 more

The history of Down syndrome–associated Alzheimer's disease; past, present, and future

Alzheimer s & Dementia(2025)10.1002/alz.70158

N/A

0.385DataRank · unranked

12 citations

María Carmona‐Iragui, Ira T. Lott, Elizabeth Head, Thomas Wisniewski, Michael S. Rafii +8 more

Diagnostic value of plasma neurofilament light: A multicentre validation study

Research Square(2020)10.21203/rs.3.rs-63386/v1

N/A

0DataRank · unranked

17 citations

Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma van der Ende, Thomas K. Karikari +36 more

Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study

The Lancet Neurology(2021)10.1016/s1474-4422(21)00129-0

N/A

0DataRank · unranked

64 citations

Daniel Alcolea, Isabel Barroeta, Laura Videla, Laia Muñoz, Kathyrn L Van Pelt +20 more

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

Journal of Clinical Medicine(2021)10.3390/jcm10215125

N/A

0DataRank · unranked

40 citations

Anke Hüls, Nicole Baumer, Mara Dierssen, Shiela Puri, Lauren Russell +15 more

The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease

Journal of Clinical Medicine(2021)10.3390/jcm10194582

N/A

0DataRank · unranked

38 citations

Eva Carrillo Félez, I. C. H. Clare, Juan Fortea, André Strydom, Anne‐Sophie Rebillat +4 more

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2021)10.1002/dad2.12184

N/A

0DataRank · unranked

30 citations

R. Asaad Baksh, Bessy Benejam, Jessica Beresford‐Webb, Antonia Coppus, Juan Fortea +14 more

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society

Molecular Syndromology(2021)10.1159/000514437

N/A

0DataRank · unranked

10 citations

Yann Hérault, Pablo Helguera, María Martínez de Lagrán, Anna Vazquez, Bradley T. Christian +29 more

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

medRxiv(2021)10.1101/2021.06.25.21259525

N/A

0DataRank · unranked

7 citations

Anke Hüls, Nicole Baumer, Mara Dierssen, Shiela Puri, Lauren Russel +14 more

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.

Apollo (University of Cambridge)(2021)10.17863/cam.71177

N/A

0DataRank · unranked

0 citations

R. Asaad Baksh, Bessy Benejam, Jessica Beresford‐Webb, Antonia Coppus, Juan Fortea +14 more

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group

Journal of Neurodevelopmental Disorders(2022)10.1186/s11689-022-09435-z

N/A

0DataRank · unranked

40 citations

Mara L. Becker, George T. Capone, Kathleen M. Egan, Juan Fortea, Benjamin L. Handen +7 more

Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society

Molecular Syndromology(2022)10.1159/000526021

N/A

0DataRank · unranked

1 citations

Lisi Flores Aguilar, Benjamin L. Handen, Marie‐Claude Potier, Ann‐Charlotte Granholm, Stephanie L. Sherman +8 more

Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring

Alzheimer s & Dementia(2024)10.1002/alz.14364

N/A

0DataRank · unranked

17 citations

Lisi Flores Aguilar, Elizabeth Head, Laia Montoliu‐Gaya, André Strydom, Sarah E. Pape +9 more

Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome

Alzheimer s & Dementia(2024)10.1002/alz.13778

N/A

0DataRank · unranked

18 citations

Richard A. Fisher, Matthew P. Janicki, Brian Chicoine, Bradley T. Christian, Anna J. Esbensen +17 more

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

Journal of Neurodevelopmental Disorders(2020)10.1186/s11689-019-9306-9

N/A

0DataRank · unranked

167 citations

Hana D’Souza, George Ball, Sarah Hamburg, Rosalyn Hithersay, Kate M. O. Hughes +5 more

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

Alzheimer s & Dementia(2025)10.1002/alz.70309

N/A

0DataRank · unranked

4 citations

Lucía Maure-Blesa, Beau M. Ances, Lisi Flores Aguilar, Sigan L. Hartley, Jason Hassenstab +54 more

Down syndrome

Nature Reviews Disease Primers(2020)10.1038/s41572-019-0143-7

N/A

0DataRank · unranked

900 citations

Brian G. Skotko, Michael S. Rafii, André Strydom, Sarah E. Pape, Diana W. Bianchi +3 more

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular Psychiatry(2020)10.1038/s41380-020-0806-5

N/A

0DataRank · unranked

123 citations

Pollyanna Goh, Aoife Murray, Erik Portelius, Eleni Gkanatsiou, Gillian Gough +41 more

“Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene-dose-sensitive AD-suppressor in human brain”

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.29.918037

N/A

0DataRank · unranked

26 citations

Pollyanna Goh, Aoife Murray, Erik Portelius, Eleni Gkanatsiou, Gillian Gough +37 more

André Strydom

Indexed papers

Top data-sharing exemplar

Papers